Gain-of-function mutations in SCN9A, the gene encoding NaV1.7, are causative of primary erythromelalgia (PE), a rare neuropathy characterised by recurring pain, warmth, and redness of the extremities. Here, SCN9A is linked to sodium channelopathy-related small fiber neuropathy.